Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changes from v3.8.0 to v3.8.1, with no change to the study details.
    Difference
    0.0%
    Check dated 2026-11-18T14:18:12.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The record for this completed ovarian cancer study is now displayed, including its treatment regimens, eligibility criteria, locations, outcomes, and study documents.
    Difference
    73%
    Check dated 2026-11-11T17:12:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-28T15:36:27.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T18:14:35.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T17:33:54.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T18:08:44.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.